Category Archives: 2020

rHEALTH’s FVIII Point-of-Care Device Awarded $1.5M Direct-to-Phase II Grant from the NIH

Grant supports efforts to utilize rHEALTH’s point-of-care technology for monitoring FVIII and emicizumab levels in hemophilia A patients BEDFORD, Mass., October 8, 2020 – rHEALTH LLC, a Diagnose Yourself, AnywhereTM company, today announced that its technology is the subject of the award from the National Institute of Health (NIH).  The award is to rHEALTH’s affiliate,...
Read more

rHEALTH Technology Granted US Patent for Small Volume Blood Handling in Point-of-Care Devices

Invention enables manipulation of small blood samples for accurate point-of-care diagnosis BEDFORD, Mass., January 5, 2020 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., announced today the issuance of United States Patent Number 10,449,537 titled “Capillary manipulation of clinical samples.”  The patent describes a system for collection and delivery of minute blood samples to...
Read more